JP2010506953A5 - - Google Patents

Download PDF

Info

Publication number
JP2010506953A5
JP2010506953A5 JP2009533511A JP2009533511A JP2010506953A5 JP 2010506953 A5 JP2010506953 A5 JP 2010506953A5 JP 2009533511 A JP2009533511 A JP 2009533511A JP 2009533511 A JP2009533511 A JP 2009533511A JP 2010506953 A5 JP2010506953 A5 JP 2010506953A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
compound
pharmaceutical composition
acceptable carrier
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009533511A
Other languages
English (en)
Japanese (ja)
Other versions
JP5343267B2 (ja
JP2010506953A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/081685 external-priority patent/WO2008049027A1/en
Publication of JP2010506953A publication Critical patent/JP2010506953A/ja
Publication of JP2010506953A5 publication Critical patent/JP2010506953A5/ja
Application granted granted Critical
Publication of JP5343267B2 publication Critical patent/JP5343267B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009533511A 2006-10-17 2007-10-17 タラロゾール代謝物 Expired - Fee Related JP5343267B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85198906P 2006-10-17 2006-10-17
US60/851,989 2006-10-17
PCT/US2007/081685 WO2008049027A1 (en) 2006-10-17 2007-10-17 Talarazole metabolites

Publications (3)

Publication Number Publication Date
JP2010506953A JP2010506953A (ja) 2010-03-04
JP2010506953A5 true JP2010506953A5 (https=) 2010-09-16
JP5343267B2 JP5343267B2 (ja) 2013-11-13

Family

ID=39314359

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009533511A Expired - Fee Related JP5343267B2 (ja) 2006-10-17 2007-10-17 タラロゾール代謝物

Country Status (10)

Country Link
US (2) US8188124B2 (https=)
EP (1) EP2114895A4 (https=)
JP (1) JP5343267B2 (https=)
KR (1) KR101419965B1 (https=)
CN (1) CN101611016B (https=)
AU (1) AU2007311026B2 (https=)
BR (1) BRPI0718310A2 (https=)
CA (1) CA2667053C (https=)
MX (1) MX2009004096A (https=)
WO (1) WO2008049027A1 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9080145B2 (en) 2007-07-01 2015-07-14 Lifescan Corporation Single pluripotent stem cell culture
CA3114827C (en) 2007-07-31 2023-09-05 Lifescan, Inc. Differentiation of human embryonic stem cells to pancreatic endocrine
EP2229434B1 (en) 2007-11-27 2011-09-07 Lifescan, Inc. Differentiation of human embryonic stem cells
KR101731474B1 (ko) 2008-02-21 2017-05-11 얀센 바이오테크 인코포레이티드 세포 부착, 배양 및 탈리를 위한 방법, 표면 개질 플레이트 및 조성물
PL2310492T3 (pl) 2008-06-30 2015-12-31 Janssen Biotech Inc Różnocowanie pluripotencjalnych komórek macierzystych
MX349178B (es) 2008-10-31 2017-07-17 Centocor Ortho Biotech Inc Diferenciación de células madre embrionarias humanas al linaje endocrino pancreático.
PL2346988T3 (pl) 2008-10-31 2017-10-31 Janssen Biotech Inc Różnicowanie ludzkich zarodkowych komórek macierzystych do linii endokrynnej trzustki
ES2642070T3 (es) 2008-11-20 2017-11-15 Janssen Biotech, Inc. Cultivo de células madre pluripotentes en microportadores
ES2584053T3 (es) 2008-11-20 2016-09-23 Janssen Biotech, Inc. Métodos y composiciones para la unión de células y cultivo en sustratos planos
KR102058901B1 (ko) 2009-07-20 2019-12-24 얀센 바이오테크 인코포레이티드 인간 배아 줄기 세포의 분화
SG181687A1 (en) 2009-12-23 2012-07-30 Centocor Ortho Biotech Inc Differentiation of human embryonic stem cells
EP2542667A4 (en) 2010-03-01 2013-07-31 Janssen Biotech Inc PROCESS FOR CLEANING CELLS OBTAINED FROM PLURIPOTENTIAL STEM CELLS
RU2663339C1 (ru) 2010-05-12 2018-08-03 Янссен Байотек, Инк. Дифференцирование эмбриональных стволовых клеток человека
EP2611907B1 (en) 2010-08-31 2016-05-04 Janssen Biotech, Inc. Differentiation of pluripotent stem cells
ES2658146T3 (es) 2010-08-31 2018-03-08 Janssen Biotech, Inc. Diferenciación de células madre embrionarias humanas
CN103221536B (zh) 2010-08-31 2016-08-31 詹森生物科技公司 人胚胎干细胞的分化
WO2013028771A1 (en) 2011-08-23 2013-02-28 Leong Hwei Xian Reversing intestinal inflammation by inhibiting retinoic acid metabolism
KR102203056B1 (ko) 2011-12-22 2021-01-14 얀센 바이오테크 인코포레이티드 인간 배아 줄기 세포의 단일 인슐린 호르몬 양성 세포로의 분화
HK1206058A1 (en) 2012-03-07 2015-12-31 Janssen Biotech, Inc. Defined media for expansion and maintenance of pluripotent stem cells
AU2013271581B2 (en) 2012-06-08 2018-08-09 Janssen Biotech, Inc. Differentiation of human embryonic stem cells into pancreatic endocrine cells
JP6557147B2 (ja) 2012-12-31 2019-08-07 ヤンセン バイオテツク,インコーポレーテツド Hb9調節物を用いたヒト胚性幹細胞の膵臓内分泌細胞への分化
BR112015015770A2 (pt) 2012-12-31 2017-07-11 Janssen Biotech Inc cultivo de células-tronco embrionárias humanas na interface ar-líquido para diferenciação em células pancreáticas endócrinas
RU2687379C2 (ru) 2012-12-31 2019-05-13 Янссен Байотек, Инк. Суспендирование и кластеризация плюрипотентных клеток человека с целью их дифференцировки в панкреатические эндокринные клетки
US10370644B2 (en) 2012-12-31 2019-08-06 Janssen Biotech, Inc. Method for making human pluripotent suspension cultures and cells derived therefrom
US10006006B2 (en) 2014-05-16 2018-06-26 Janssen Biotech, Inc. Use of small molecules to enhance MAFA expression in pancreatic endocrine cells
DK3443073T3 (da) 2016-04-14 2024-09-02 Janssen Biotech Inc Differentiering af pluripotente stamceller til intestinale mellemtarmendodermceller

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997049704A1 (en) * 1996-06-27 1997-12-31 Janssen Pharmaceutica N.V. N-[4-(heteroarylmethyl)phenyl]-heteroarylamines
AP869A (en) 1998-01-05 2000-09-04 Pfizer 2,3-Substituted indole compounds as anti-inflammatory and analgesic agents.
CN1596240A (zh) * 2001-12-19 2005-03-16 阿特罗吉尼克斯公司 查耳酮衍生物及其治疗疾病的用途
US20060205945A1 (en) * 2004-05-14 2006-09-14 Pfizer Inc Pyrimidine derivatives for the treatment of abnormal cell growth
PL372356A1 (pl) * 2005-01-20 2006-07-24 ADAMED Sp.z o.o. Nowe związki, pochodne kwasu 3-fenylopropionowego
TW200639163A (en) * 2005-02-04 2006-11-16 Genentech Inc RAF inhibitor compounds and methods

Similar Documents

Publication Publication Date Title
JP2010506953A5 (https=)
EP2396081B1 (en) Alkylamido compounds and uses thereof
JP2009519993A5 (https=)
JP5343267B2 (ja) タラロゾール代謝物
JP2015501820A5 (https=)
JP2011518833A5 (https=)
RU2007119380A (ru) Косметические продукты, предназначенные для ухода за собой, включающие соли дигидроксипропилтри (c1-c3алкил) аммония
JP2009502743A5 (https=)
JP2007051159A5 (https=)
JP2010530373A5 (https=)
JP2013515006A5 (https=)
JP2007511546A5 (https=)
JP2012144574A5 (https=)
JP2009543799A5 (https=)
JP2007302689A5 (https=)
JP2007515465A5 (https=)
CA2595544A1 (en) Compounds having analgesic and/or immunostimulant activity
JP2006515613A5 (https=)
CN110382463A (zh) Hdac6选择性抑制剂及其制备方法和应用
EP2308828A3 (en) CaSR antagonist
BRPI0518647A2 (pt) processo para a produÇço de um composto, e, composto
WO2009134531A3 (en) Total synthesis of salinosporamide a and analogs thereof
JP2007502832A5 (https=)
JP2018145180A5 (https=)
JP2010209099A5 (https=)